Surgery Doctors in Tuba City, AZ Accepting Medicare

5 Surgery doctors found. Showing 1 - 5

Thomas J Drouhard, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 167 North Main Street, Tuba City, AZ 86045 Phone: 928-283-2501    Fax: 928-283-2677

Dr. Vanessa Jensen, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 167 N. Main Street, Tuba City, AZ 86045 Phone: 928-283-2501    Fax: 928-283-2677

Dhriti Mukhopadhyay, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 167 N Main St, Tuba City, AZ 86045 Phone: 928-283-2501

Joachim D Chino, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 167 North Main Street, Tuba City, AZ 86045 Phone: 928-283-2501    Fax: 928-283-2677

Dr. Adela Lente, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 167 N. Main, Tuba City, AZ 86045 Phone: 928-283-2406

News Archive

Study: Stem cell transplant effective in halting degenerative disc disease of spine

Stem cell transplant was viable and effective in halting or reversing degenerative disc disease of the spine, a meta-analysis of animal studies showed, in a development expected to open up research in humans.

Genentech announces Phase II RG7204 clinical study results for metastatic melanoma tumors

Genentech, Inc., a member of the Roche Group today announced results from a Phase II clinical study of RG7204 (PLX4032), an investigational first-in-class molecule designed to selectively inhibit a cancer-causing, mutated form of the BRAF protein found in approximately half of metastatic melanoma tumors.

Scientists create animal models by altering specific genes associated with a given disease

Whitehead Institute Founding Member Rudolf Jaenisch, who helped transform the study of genetics by creating the first transgenic mouse in 1974, is again revolutionizing how genetically altered animal models are created and perhaps even redefining what species may serve as models.

Scientists develop new synthetic material to grow stem cells

Human pluripotent stem cells, which can become any other kind of body cell, hold great potential to treat a wide range of ailments, including Parkinson's disease, multiple sclerosis and spinal cord injuries. However, scientists who work with such cells have had trouble growing large enough quantities to perform experiments - in particular, to be used in human studies. Furthermore, most materials now used to grow human stem cells include cells or proteins that come from mice embryos, which help stimulate stem-cell growth but would likely cause an immune reaction if injected into a human patient.

European CHMP issues positive opinion to Vertex's KALYDECO for treatment of CF

Vertex Pharmaceuticals Incorporated announced today that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion by consensus recommending the approval of KALYDECO (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Read more Medical News

› Verified 3 days ago